Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlo Bruno

Showing results (11-20 of 34) with videos related to

Pageof 4
Sort By:
European Journal of Preventive Cardiology|March 23, 2021
Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trialGiovanni Cioffi, Carlo Bruno Giorda, Donata Lucci, et al.
BMJ Open Diabetes Research & Care|September 15, 2020
Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysisCarlo Bruno Giorda, Federico Pisani, Alberto De Micheli, et al.
Cardiovascular Drugs and Therapy|August 17, 2019
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study PopulationCarlo Bruno Giorda, Giovanni Cioffi, Donata Lucci, et al.
The Journal of Physical Chemistry. B|January 29, 2009
Electrochemical and theoretical investigation of corannulene reduction processesCarlo Bruno, Rois Benassi, Alessio Passalacqua, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2020
Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) StudyCarlo Bruno Giorda, Emanuela Orsi, Salvatore De Cosmo, et al.
The Journal of Physical Chemistry. B|June 18, 2010
Experimental and theoretical study of the p- and n-doped states of alkylsulfanyl octithiophenesCarlo Bruno, Francesco Paolucci, Massimo Marcaccio, et al.
Inorganic Chemistry|January 18, 2006
A new family of ruthenium(II) polypyridine complexes bearing 5-aryltetrazolate ligands as systems for electrochemiluminescent devicesStefano Stagni, Antonio Palazzi, Stefano Zacchini, et al.
Acta Diabetologica|November 26, 2009
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective studyGiuseppina Tiziana Russo, Antonino Di Benedetto, Domenico Magazzù, et al.
Stroke|March 3, 2007
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI studyCarlo Bruno Giorda, Angelo Avogaro, Marina Maggini, et al.
Diabetes/Metabolism Research and Reviews|June 11, 2025
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert GroupConcetta Irace, Angelo Avogaro, Federico Bertuzzi, et al.
Pageof 4

Showing results (11-20 of 34) with videos related to

Sort By:
Pageof 4
European Journal of Preventive Cardiology|March 23, 2021
Effects of linagliptin on left ventricular DYsfunction in patients with type 2 DiAbetes and concentric left ventricular geometry: results of the DYDA 2 trialGiovanni Cioffi, Carlo Bruno Giorda, Donata Lucci, et al.
BMJ Open Diabetes Research & Care|September 15, 2020
Determinants of good metabolic control without weight gain in type 2 diabetes management: a machine learning analysisCarlo Bruno Giorda, Federico Pisani, Alberto De Micheli, et al.
Cardiovascular Drugs and Therapy|August 17, 2019
Effects of Dipeptidyl Peptidase-4 Inhibitor Linagliptin on Left Ventricular Dysfunction in Patients with Type 2 Diabetes and Concentric Left Ventricular Geometry (the DYDA 2™ Trial). Rationale, Design, and Baseline Characteristics of the Study PopulationCarlo Bruno Giorda, Giovanni Cioffi, Donata Lucci, et al.
The Journal of Physical Chemistry. B|January 29, 2009
Electrochemical and theoretical investigation of corannulene reduction processesCarlo Bruno, Rois Benassi, Alessio Passalacqua, et al.
Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders|August 1, 2020
Prescription of Sulphonylureas among Patients with Type 2 Diabetes Mellitus in Italy: Results from the Retrospective, Observational Multicentre Cross-Sectional SUSCIPE (Sulphonyl_UreaS_Correct_Internal_Prescription_Evaluation) StudyCarlo Bruno Giorda, Emanuela Orsi, Salvatore De Cosmo, et al.
The Journal of Physical Chemistry. B|June 18, 2010
Experimental and theoretical study of the p- and n-doped states of alkylsulfanyl octithiophenesCarlo Bruno, Francesco Paolucci, Massimo Marcaccio, et al.
Inorganic Chemistry|January 18, 2006
A new family of ruthenium(II) polypyridine complexes bearing 5-aryltetrazolate ligands as systems for electrochemiluminescent devicesStefano Stagni, Antonio Palazzi, Stefano Zacchini, et al.
Acta Diabetologica|November 26, 2009
Mild hyperhomocysteinemia, C677T polymorphism on methylenetetrahydrofolate reductase gene and the risk of macroangiopathy in type 2 diabetes: a prospective studyGiuseppina Tiziana Russo, Antonino Di Benedetto, Domenico Magazzù, et al.
Stroke|March 3, 2007
Incidence and risk factors for stroke in type 2 diabetic patients: the DAI studyCarlo Bruno Giorda, Angelo Avogaro, Marina Maggini, et al.
Diabetes/Metabolism Research and Reviews|June 11, 2025
Enhancing Type 2 Diabetes Care With CGM Integration: Insights From an Italian Expert GroupConcetta Irace, Angelo Avogaro, Federico Bertuzzi, et al.
Pageof 4